Intestinal epithelial and immune cells

Intestinal epithelial and immune cells constitute the primary interface between the host and the external environment in the gastrointestinal tract, playing a critical role in nutrient absorption and immune surveillance (Mowat & Agace, 2014, Nature Reviews Immunology). The intestinal epithelium serves as a physical and chemical barrier, while specialized immune cells within the lamina propria and gut-associated lymphoid tissue (GALT) maintain tolerance to commensal bacteria and respond to pathogens (Okumura & Takeda, 2017, Nature Reviews Immunology). Dysregulation of the crosstalk between these cellular components is central to the pathogenesis of inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis (Xavier & Podolsky, 2007, Nature). Therapeutic strategies often target specific molecular pathways within these cells, such as the alpha-4 beta-7 integrin on lymphocytes to prevent their recruitment to the intestinal mucosa (Sandborn et al., 2013, NEJM). Other treatments involve neutralizing pro-inflammatory cytokines like TNF-alpha or IL-12/23 that are produced by or act upon these cell populations to reduce chronic inflammation. Consequently, while this term describes a tissue compartment or cell population rather than a single protein target, it is the focal point for many gastrointestinal therapies aimed at restoring barrier integrity and immune homeostasis.

Other names

Intestinal mucosaGut-associated lymphoid tissueGALTIntestinal barrierMucosal immune system

Modulation of mucosal immunity and barrier function through various molecular pathways including cytokine neutralization, leukocyte trafficking inhibition, and intracellular signaling blockade.